Company / Revenue per Share
Biogen Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$68.26
FY2025
5-year range
$63.04 / $68.26
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
#6 of 152
Health Care
What the data says
Among 152 Health Care companies, Biogen is in the top 4% for revenue per share. Revenue per Share has increased for 4 consecutive years, from $63.04 in FY2021 to $68.26 in FY2025.
Based on SEC 10-K filings.
68.26 in FY2025 with a 5-year CAGR of +0.0%. Top quartile in the Health Care sector.
Improved from $66.91 to $68.26 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 152This company $68.26 Sector average $10.34
▼
+560.3% above sector average
Key checks
Key Insights
- Biogen's revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 1.6% year-over-year.
- Ranks #6 out of 152 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.26 | +1.6% |
| FY2024 | $67.19 | +0.4% |
| FY2023 | $66.91 | +0.2% |
| FY2022 | $66.75 | +5.9% |
| FY2021 | $63.04 | -7.5% |
| FY2020 | $68.18 | +0.3% |
| FY2019 | $67.98 | +9.1% |
| FY2018 | $62.31 | +9.6% |
| FY2017 | $56.85 | +8.5% |
| FY2016 | $52.37 | +14.1% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026